Theodore Harris - Balchem President CEO, Director
| BL9B Stock | EUR 166.20 2.50 1.53% |
CEO
Mr. Theodore L. Harris is Chairman of the Board, President, Chief Executive Officer of the Company. He was a director, and President and Chief Executive Officer of the Company since April 2015, and Chairman of the Companys Board of Directors since January 2017. Prior to joining the Company, Mr. Harris was employed by Ashland Global Holdings Inc., a specialty chemical company, in various senior management positions, serving as Senior Vice President, President Performance Materials, from November of 2014 to April 2015. Prior to this position, from 2011 to 2014, he served as Senior Vice President, President Performance Materials Ashland Supply Chain, and prior to that, Vice President, President Performance Materials Ashland Supply Chain. Mr. Harris broad managerial, international, operational and sales experience, as well as his proven track record of developing and implementing strategies for delivering sustainable, profitable growth, make him a valuable member of our Board of Directors. Mr. Harris is also a member of the board of directors of Pentair plc, a diversified industrial manufacturing company. since 2017.
| Age | 58 |
| Tenure | 7 years |
| Phone | 845 326 5600 |
| Web | https://www.balchem.com |
Theodore Harris Latest Insider Activity
Tracking and analyzing the buying and selling activities of Theodore Harris against Balchem stock is an integral part of due diligence when investing in Balchem. Theodore Harris insider activity provides valuable insight into whether Balchem is net buyers or sellers over its current business cycle. Note, Balchem insiders must abide by specific rules, including filing SEC forms every time they buy or sell Balchem'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Theodore Harris over six months ago Acquisition by Theodore Harris of 2256 shares of Pentair PLC subject to Rule 16b-3 |
Balchem Management Efficiency
The company has return on total asset (ROA) of 0.065 % which means that it generated a profit of $0.065 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.122 %, meaning that it generated $0.122 on every $100 dollars invested by stockholders. Balchem's management efficiency ratios could be used to measure how well Balchem manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 2 records | CEO Age | ||
| Stephen Burns | Hollywood Bowl Group | 39 | |
| Jon Barker | Sportsmans Warehouse Holdings | 55 | |
Management Performance
| Return On Equity | 0.12 | |||
| Return On Asset | 0.065 |
Balchem Leadership Team
Elected by the shareholders, the Balchem's board of directors comprises two types of representatives: Balchem inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Balchem. The board's role is to monitor Balchem's management team and ensure that shareholders' interests are well served. Balchem's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Balchem's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Frederic Boned, VP Health | ||
| CPA CPA, Chief Officer | ||
| Hatsuki Miyata, Gen Sec | ||
| Carl Bengtsson, CFO Treasurer | ||
| Theodore Harris, President CEO, Director | ||
| Mark Stach, General Counsel, Secretary | ||
| Jonathan Griffin, VP Health | ||
| Martin Reid, Chief Officer |
Balchem Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Balchem a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.12 | |||
| Return On Asset | 0.065 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.16 % | |||
| Current Valuation | 4.36 B | |||
| Shares Outstanding | 32.14 M | |||
| Shares Owned By Insiders | 0.93 % | |||
| Shares Owned By Institutions | 91.24 % | |||
| Price To Earning | 38.08 X | |||
| Price To Book | 4.33 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Balchem Stock
When determining whether Balchem offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Balchem's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Balchem Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Balchem Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Balchem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more detail on how to invest in Balchem Stock please use our How to Invest in Balchem guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.